{"id":"W1993607717","doi":"10.1111/j.1365-2893.2006.00816.x","title":"Therapeutic issues in HIV/HCV‐coinfected patients","year":2006,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; National Institute on Drug Abuse; Vertex Pharmaceuticals; Gilead Sciences","keywords":"Medicine; Ribavirin; Coinfection; Pegylated interferon; Hepatitis C; Hepatitis C virus; Internal medicine; Population; Immunology; Intensive care medicine; Human immunodeficiency virus (HIV); Virus","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00117593,0.0007526152,0.002216834,0.001675928,0.0004023086,0.001082424,0.0009250226,0.001776998,0.00263751],"category_scores_gemma":[0.001937083,0.0002303494,0.0005696486,0.001752847,0.000553769,0.001387658,0.000505485,0.001474273,0.001385006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000595604,"about_ca_system_score_gemma":0.001069503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000777937,"about_ca_topic_score_gemma":0.001426842,"domain_scores_codex":[0.9994204,0.0002553732,0.00009076233,0.00004792728,0.0001552025,0.00003028715],"domain_scores_gemma":[0.9994967,0.0002708784,0.0001018815,0.00001141667,0.00008881969,0.00003037966],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001243469,0.0001001216,0.0003346115,0.02912022,0.000135881,0.001485513,0.0001749733,0.0001994388,0.001011332,0.001884283,0.02857016,0.936859],"study_design_scores_gemma":[0.0001385839,0.0002975799,0.002677972,0.01938759,0.0003591365,0.0169813,0.0004073639,0.0001591,0.0005873194,0.003224458,0.9557428,0.00003690533],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008931009,0.9987808,0.00004679383,0.0004291779,0.0001133143,0.000004158499,0.000002537493,0.000003220808,0.0005306591],"genre_scores_gemma":[0.001170267,0.9977323,0.0001927439,0.0004399248,0.0002096109,0.00001031424,0.000007318226,7.856026e-7,0.0002367137],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00263751,"threshold_uncertainty_score":0.008823335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04664782216823437,"score_gpt":0.3968295823683239,"score_spread":0.3501817602000895,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}